Literature DB >> 12002738

The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease.

L Grönke1, F Kanniess, O Holz, R A Jörres, H Magnussen.   

Abstract

BACKGROUND: The combination of airway hyper-responsiveness, eosinophilic airway inflammation, and lung function impairment is considered as a hallmark of bronchial asthma. Since airway function might change with time in chronic asthma, the association between parameters which are characteristic of asthma could be different in subjects with different durations of the disease.
OBJECTIVE: We assessed whether in patients with asthma the relationship between airway hyperresponsiveness, non-invasive markers of airway inflammation, and baseline lung function depended on the duration of the disease.
METHODS: Sixty-six non-smoking patients with mild to moderate allergic asthma without corticosteroids were assigned to two groups, according to a duration of the disease (time interval since doctor's diagnosis) of either < or = 16 years (median 8 years; mean FEV1, 92.6% pred.; n = 34) or > 16 year (median 25 years; mean FEV1, 87.9% pred.; n = 32).
RESULTS: Groups did not differ statistically in PC20FEV1 of methacholine, sputum composition, levels of exhaled nitric oxide (NO), lung function parameters, or history of treatment. There were significant correlations between PC20FEV1, eosinophils and NO in patients with a duration of the disease < or = 16 year, but no relation to lung function. In contrast, patients with a duration > 16 year showed a correlation between PC20FEV1 of methacholine and lung function but not eosinophils or NO. In both groups, eosinophils and NO were associated with each other. These results were corroborated by the statistical procedure of factor analysis that revealed 'inflammation' and 'lung function' as major entities and found 'responsiveness' to be associated with only one of them in each group.
CONCLUSION: Our data demonstrate that with a shorter duration of the asthmatic disease airway hyper-responsiveness is associated with airway inflammation, whereas with a longer duration it is associated with impaired lung function, suggesting that in chronic asthma ongoing alterations become the primary determinant of functional characteristics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12002738     DOI: 10.1046/j.0022-0477.2001.01297.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  8 in total

1.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

2.  Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis.

Authors:  T F Leung; G W K Wong; F W S Ko; C W K Lam; T F Fok
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

3.  FeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management.

Authors:  Marcello Verini; Nicola Pietro Consilvio; Sabrina Di Pillo; Anna Cingolani; Cynzia Spagnuolo; Daniele Rapino; Alessandra Scaparrotta; Francesco Chiarelli
Journal:  J Allergy (Cairo)       Date:  2010-05-18

4.  Identifying the components of asthma health status in children with mild to moderate asthma.

Authors:  Elizabeth W Holt; Earl Francis Cook; Ronina A Covar; Joseph Spahn; Anne L Fuhlbrigge
Journal:  J Allergy Clin Immunol       Date:  2008-05       Impact factor: 10.793

5.  Measuring systemic inflammatory regulation in older adults: evidence and utility.

Authors:  Karen Bandeen-Roche; Jeremy D Walston; Yi Huang; Richard D Semba; Luigi Ferrucci
Journal:  Rejuvenation Res       Date:  2009-12       Impact factor: 4.663

6.  Longitudinal measurement of airway inflammation over one year in children and adults with intermittent asthma.

Authors:  Frauke Pedersen; Olaf Holz; Frank Kanniess; Stefan Zielen; Johannes Schulze; Adrian Gillissen; Andrea von Berg; Dietrich Berdel; Jutta Beier; Kai Beeh; Maike Schnoor; Helgo Magnussen
Journal:  BMC Res Notes       Date:  2014-12-17

Review 7.  Physiopathology of airway hyperresponsiveness.

Authors:  Louis-Philippe Boulet
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

8.  Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care.

Authors:  David Price; Dermot Ryan; Annie Burden; Julie Von Ziegenweidt; Shuna Gould; Daryl Freeman; Kevin Gruffydd-Jones; Anne Copland; Clifford Godley; Alison Chisholm; Mike Thomas
Journal:  Clin Transl Allergy       Date:  2013-11-07       Impact factor: 5.871

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.